A possible explanation could be the molecular mimicry between SARS-CoV-2 viral proteins and cardiac structures or a nonspecific systemic inflammatory response secondary to vaccination (1).
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Pharmacovigilance related to heart damage is of paramount importance at this early stage of massive coronavirus disease 2019 (COVID-19) campaigns to identify the profile of patients at risk.
📊
Key Findings & Data:Systemic reactogenicity, which leads to systemic adverse events, often occur after the second dose.
💡
Conclusion & Impact:A possible explanation could be the molecular mimicry between SARS-CoV-2 viral proteins and cardiac structures or a nonspecific systemic inflammatory response secondary to vaccination (1).
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters
Özet
Pharmacovigilance related to heart damage is of paramount importance at this early stage of massive coronavirus disease 2019 (COVID-19) campaigns to identify the profile of patients at risk. Systemic reactogenicity, which leads to systemic adverse events, often occur after the second dose. A possible explanation could be the molecular mimicry between SARS-CoV-2 viral proteins and cardiac structures or a nonspecific systemic inflammatory response secondary to vaccination (1).
🔖
Cite This Article
CEREDA, A., CONCA, C., BARBİERİ, L., FERRANTE, G., TUMMİNELLO, G., LUCREZİOTTİ, S., GUAZZİ, M., MAFRİCİ, A. (2021). Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?. The Anatolian Journal of Cardiology, Cilt: 25 - Sayı: 7, 522–523. https://ajindex.com/articles/365115
Ammirati E, Cavalotti C, Milazzo A, Pedrotti P, Soriano F, Schroeder JW, et al. Temporal Relation Between Second Dose BNT162b2 mRNA Covid-19 Vaccine and Cardiac involvement in a Patient with Previous SARS-COV-2 Infection. Int J Cardiol Heart Vasc 2021: 100778. [Crossref] 2. el-Khatib M, Lerner AM. Myocarditis in Mycoplasma pneumoniae pneumonia. Occurrence with hemolytic anemia and extraordinary titers of cold isohemagglutinins. JAMA 1975; 231: 493-4. [Crossref] 3. Su JR, McNeil MM, Welsh KJ, Marquez PL, Ng C, Yan M, et al. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018. Vaccine 2021; 39: 839-45. [Crossref] 4. Nagano N, Yano T, Fujita Y, Koyama M, Hasegawa R, Nakata J, et al. Hemodynamic Collapse After Influenza Vaccination: A Vaccine- Induced Fulminant Myocarditis? Can J Cardiol 2020; 36: 1554.e5-7. [Crossref] 5. Mele D, Flamigni F, Rapezzi C, Ferrari R. Myocarditis in COVID-19 patients: current problems. Intern Emerg Med 2021: 1-7. [Crossref] 6. Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol 2021; 50: 107300. [Crossref]